|
Home Page
About Us
Investors
Inventors
Justin M. Balko, Pharm.D., Ph.D.
E. Penni Black, Ph.D.
Albert R. Cunningham, Ph.D.
Robert Falk, M.D.
George N. Hajishengallis, D.D.S., Ph.D.
Ted Kalbfleisch, Ph.D.
Y. James Kang, Ph.D.
Claudio Maldonado, Ph.D.
Gustavo A. Perez-Abadia, M.D.
William Pierce, Ph.D.
Norman D. Radtke, M.D.
Fred J. Roisen, Ph.D.
Haval Shirwan, Ph.D.
Audra Stinchcomb, Ph.D.
Roland Valdes, Jr., Ph.D.
Portfolio
Contact Us
Privacy Policy
|
|
|
|
Inventors - George N. Hajishengallis, D.D.S., Ph.D.
|
|
George N. Hajishengallis, D.D.S., Ph.D., AnosiaVax, Inc.
George Hajishengallis, D.D.S., Ph.D. is founder and CEO of AnosiaVax, Inc. and a UofL professor and University Scholar in the departments of Periodontics/Endodontics and Microbiology/Immunology.
AnosiaVax, built on Dr. Hajishengallis' research, is developing safe and effective adjuvants in mucosal vaccine formulations against pathogens which invade via oral, respiratory, gastic or urogenital routes.
Dr. Hajishengallis obtained a D.D.S. in 1989 from the University of Athens, Greece and a Ph.D. in cellular and molecular biology in 1994 from the University of Alabama at Birmingham. He pursued postdotal work at UAB and at the State University of New York at Buffalo.
He was recruited to the University of Louisville from Louisiana State University in 2005, and wone the UofL Faculty Excellence Honor in 2006. He is currently a professor and a principal investigator at the UofL Oral Health and Systemic Disease Group.
Dr. Hajishengallis has published more than 65 peer-reviewed papers, and his research is currently supported by three R01 grants by the National Institute of Dental and Craniofacial Research.
|
|
|
